Recently, many studies had found that maternally expressed 3 (MEG3) inhibited non-small cell lung cancer (NSCLC) cell proliferation and that MEG3 was associated with a poor prognosis and promoted cell proliferation in gastric cancer [31, 32]. Here, MEG3 is linked to non-small cell lung carcinoma.